Bizzari Jean-Pierre
- SEC CIK
- 0001630914
No open-market purchases or sales filed in the past year.
Current role at each company
- APRE Aprea Therapeutics, Inc.Directoras of Jun 17, 2026
- ADCT ADC Therapeutics SADirectoras of Jun 3, 2026
- HALO Halozyme Therapeutics, Inc.Directoras of May 9, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bizzari Jean-Pierre as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADCT ADC Therapeutics SA
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 (view filing) | Jun 17 | 1 day | Bizzari Jean-PierreDirector | SSale | −7.00K | $2.89 | −$20.2K | −8.1%79.5K after |
HALO Halozyme Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2021 (view filing) | Aug 25 | Same day | Bizzari Jean-PierreDirector | SSale | −35.0K | $41.01 | −$1.44M | −40.0%52.5K after |